EsophyX
Device Gerd
General payments
$1,525,922
Research payments
$1,497,784
Through program year 2024, $1,525,922 in general payments and $1,497,784 in research payments were reported against EsophyX (Gerd).
No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.
By program year
12 rows| Year | Kind | Amount | Payments |
|---|---|---|---|
| 2024 | General | $196,738 | 933 |
| 2024 | Research | $128,640 | 2 |
| 2023 | General | $312,216 | 1,580 |
| 2023 | Research | $208,227 | 5 |
| 2022 | General | $358,626 | 1,429 |
| 2022 | Research | $402,525 | 8 |
| 2021 | General | $212,233 | 498 |
| 2021 | Research | $381,617 | 16 |
| 2020 | General | $135,687 | 402 |
| 2020 | Research | $196,005 | 7 |
| 2019 | General | $310,423 | 1,269 |
| 2019 | Research | $180,770 | 10 |
Breakdown
The top 5 of the 100 largest recipients; each share is of general payments naming this product in 2024.
The top 5 of 40 specialties; each share is of general payments naming this product to practitioners with a specialty in 2024. Each practitioner is counted under their primary specialty.
The top 5 of 42 states; each share is of general payments naming this product in 2024 where a state was reported.
Records
6,111 general · 48 researchEvery payment, record by record
Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.
What you are looking at
Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.